Live news related to SANOFI stock (FR0000120578): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The Chinese National Medical Products Administration has approved two Sanofi-licensed drugs, according to the company's statement. These are Myqorzo (…
Sanofi's stock has risen by 2.55% at midday on Wednesday, January 14, after testing its support threshold at 80.50 euros the previous day. This reboun…
Sanofi's stock closed down 2.32% at 80.50 euros this Tuesday, January 13, touching its support threshold at 80.60 euros. This challenging session come…
The European Commission has approved the marketing of Tzield (teplizumab), a treatment developed by Sanofi intended to delay the progression to stage …
The stock of the French pharmaceutical giant increased by 1.87% this Friday, January 9, closing at 84.44 euros after a session marked by renewed inves…
